Aetiology and pathogenesis of multiple sclerosis

Hospital Pharmacist

Volumn 10, Issue 1, 2003, Pages 13-16

  Niepel, Graham G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; GENETIC PREDISPOSITION; HEREDITY; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0037236381     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.
2. Lubin F, Reingold S. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (US) Advisory Committee on Clinical Trials of New Agents in multiple sclerosis. Neurology 1996;46:907-11.
3. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31.
4. Sadovnick AD, Armstrong H, Kice GP, Bulman D, Hashimoto L, Paty D et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-5.
5. Barcellos LF, Oksenburg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S et al. Genetic basis for clinical expression in multiple sclerosis. Brain 2002;125:150-8.
6. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al. Linkage of MHC to familial multiple sclerosis suggests genetic heterogeneity. Human Molec Genetics 1988;7:1229-34.
7. Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M et al. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 2001;56:312-6.
8. Friedman JE, Lyons MJ, Abashl DV, Whitman JE, Edgar Met al. The association of the human herpes virus-6 and multiple sclerosis. Mult Scler 1999;5:355-62.
9. Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oetde H, Siegert W. A potential role for human herpes virus type 6 in nervous system disease. J Neuroimmunol 1994;49:213-4.
10. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983;40:406-8.
11. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999;46:6-14.
12. Wucherpfennig K. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097-104.
13. Confavreux C, Vukusic S. Natural history of multiple sclerosis: implications for counselling and therapy: Curr Opin Neurol 2002;15:257-66.
14. Lucchinetti C, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-17.
15. Constantinescu CS, Hilliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM. Pathogenesis of neuroimmunologic disorders: experimental models. Immunol Res 1998;17:217-27.
16. Lafaille JL, van de Keere FV, Hsu AL, Baron JL, Haas W, Raine CS et al. Myelin basic protein-specific T helper 2 cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 1997;186:307-12.
17. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57B1/6 mice. J Immunol 2001;166:7579-87.
18. Raine CS, Cannella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999;46:144-60.
19. Schluessner HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against myelin oligodendrocyte glycoprotein induces relapses and demyelination in a Central Nervous System autoimmune disease. J Immunol 1987;139:4016-21.
20. Lehmann PV, Forsthuber T, Miller A, Sercarz E. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358:155-7.